Characterization of the Interaction Between DARPP-32 and Protein Phosphatase 1 (PP-1): DARPP-32 Peptides Antagonize the Interaction of PP-1 with Binding Proteins
Overview
Affiliations
The catalytic subunit of PP-1 (PP-1C) is potently inhibited (IC50, approximately 1 nM) by DARPP-32 (dopamine- and cAMP-regulated phosphoprotein, M(r) 32,000), inhibitor-1, and inhibitor-2. The NH2-terminal 50 amino acid residues of DARPP-32 and inhibitor-1 are similar, and phosphorylation of a common threonine residue (Thr-34/Thr-35) is necessary for inhibition of PP-1C. We have characterized further the interaction between DARPP-32 and PP-1C. Using synthetic peptides derived from the NH2-terminal region of DARPP-32, residues 6-11, RKKIQF, have been shown to be required for inhibition of PP-1C. Peptides containing this motif were able to antagonize the inhibition of PP-1C by phospho-DARPP-32 and phosphoinhibitor-1. The inhibition of PP-1C by inhibitor-2, but not by okadaic acid, microcystin, or calyculin A, was also attentuated by these antagonist peptides. These results together with results from other studies support a model in which two subdomains of phospho-DARPP-32 interact with PP-1C. The region encompassing phospho-Thr-34 appears to interact with the active site of the enzyme blocking enzyme activity. The region encompassing the RKKIQF motif binds to a domain of PP-1C removed from the active site. Amino acid sequence analysis indicates that basic and hydrophobic features of the RKKIQF motif are conserved in the binding domains of certain PP-1C targeting proteins, suggesting that interaction of inhibitor proteins and targeting proteins may be mutually exclusive.
Substrate and phosphorylation site selection by phosphoprotein phosphatases.
Nguyen H, Kettenbach A Trends Biochem Sci. 2023; 48(8):713-725.
PMID: 37173206 PMC: 10523993. DOI: 10.1016/j.tibs.2023.04.004.
Srivastava G, Bajaj R, Kumar G, Gaudreau-LaPierre A, Nicolas H, Chamousset D Cell Rep. 2022; 41(9):111726.
PMID: 36450254 PMC: 9813921. DOI: 10.1016/j.celrep.2022.111726.
Short peptide pharmacophores developed from protein phosphatase-1 disrupting peptides (PDPs).
Fontanillo M, Trebacz M, Reinkemeier C, Aviles Huerta D, Uhrig U, Sehr P Bioorg Med Chem. 2022; 65:116785.
PMID: 35525109 PMC: 7613447. DOI: 10.1016/j.bmc.2022.116785.
Regulation of Synaptic Transmission and Plasticity by Protein Phosphatase 1.
Foley K, McKee C, Nairn A, Xia H J Neurosci. 2021; 41(14):3040-3050.
PMID: 33827970 PMC: 8026358. DOI: 10.1523/JNEUROSCI.2026-20.2021.
Wang X, Obeidat M, Li L, Pasarj P, Aburahess S, Holmes C J Biol Chem. 2019; 294(36):13280-13291.
PMID: 31315927 PMC: 6737228. DOI: 10.1074/jbc.RA118.006075.